Journal of Pharmaceutical Analysis and Drug Research ISSN: 3108-0839 (Online)

Authors: Udita Verma, Nitin Tyagi

Abstract: Mental health disorders such as depression, anxiety, bipolar disorder, and schizophrenia pose significant challenges to global health. Despite existing treatments, many patients experience suboptimal outcomes, underscoring the need for new and more effective drugs. This paper explores recent advancements in drug development for these conditions, focusing on novel therapeutic targets and mechanisms of action. The paper also discusses the complexities and challenges of mental health drug development, including the heterogeneity of disorders, clinical trial design, safety concerns, and lengthy development timelines. Future directions emphasize personalized medicine, digital health integration, and collaborative research efforts.

Keywords: Depression, Anxiety, Bipolar Disorder, Schizophrenia, Drug Development, Ketamine, Cannabidiol, Circadian Rhythm, Glutamate System, Personalized Medicine